Geraint Davies

5.4k total citations
136 papers, 3.0k citations indexed

About

Geraint Davies is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Geraint Davies has authored 136 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Infectious Diseases, 61 papers in Epidemiology and 21 papers in Pharmacology. Recurrent topics in Geraint Davies's work include Tuberculosis Research and Epidemiology (85 papers), Mycobacterium research and diagnosis (28 papers) and Pneumocystis jirovecii pneumonia detection and treatment (21 papers). Geraint Davies is often cited by papers focused on Tuberculosis Research and Epidemiology (85 papers), Mycobacterium research and diagnosis (28 papers) and Pneumocystis jirovecii pneumonia detection and treatment (21 papers). Geraint Davies collaborates with scholars based in United Kingdom, South Africa and Malawi. Geraint Davies's co-authors include D.A. Mitchison, Charles A. Peloquin, Saye Khoo, Derek J. Sloan, A. Willem Sturm, Christian Lienhardt, David Wilkinson, Catherine Connolly, David Wilkinson and Stephen A. Ward and has published in prestigious journals such as Nature Medicine, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Geraint Davies

131 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geraint Davies United Kingdom 31 2.1k 1.5k 559 423 352 136 3.0k
Patrick Phillips United Kingdom 33 2.2k 1.1× 1.6k 1.1× 802 1.4× 359 0.8× 255 0.7× 120 3.4k
Rovina Ruslami Indonesia 25 2.0k 0.9× 1.4k 0.9× 1.1k 1.9× 298 0.7× 334 0.9× 107 3.1k
Amour Venter South Africa 27 2.3k 1.1× 1.7k 1.2× 713 1.3× 714 1.7× 356 1.0× 43 2.8k
Marc Weiner United States 35 3.3k 1.6× 2.5k 1.7× 1.1k 2.1× 414 1.0× 354 1.0× 77 4.0k
Jotam G. Pasipanodya United States 35 2.7k 1.3× 2.0k 1.3× 565 1.0× 424 1.0× 957 2.7× 86 3.5k
Lubbe Wiesner South Africa 32 2.0k 1.0× 1.1k 0.7× 291 0.5× 481 1.1× 511 1.5× 246 3.6k
Kelly E. Dooley United States 36 3.5k 1.7× 2.4k 1.7× 1.3k 2.4× 577 1.4× 418 1.2× 141 4.6k
Rodney Dawson South Africa 38 3.3k 1.6× 2.5k 1.7× 1.1k 2.0× 808 1.9× 410 1.2× 82 4.4k
Paolo Denti South Africa 27 1.4k 0.7× 745 0.5× 363 0.6× 355 0.8× 511 1.5× 159 2.6k
Shashikant Srivastava United States 32 2.2k 1.0× 1.8k 1.2× 424 0.8× 434 1.0× 727 2.1× 126 2.9k

Countries citing papers authored by Geraint Davies

Since Specialization
Citations

This map shows the geographic impact of Geraint Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geraint Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geraint Davies more than expected).

Fields of papers citing papers by Geraint Davies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geraint Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geraint Davies. The network helps show where Geraint Davies may publish in the future.

Co-authorship network of co-authors of Geraint Davies

This figure shows the co-authorship network connecting the top 25 collaborators of Geraint Davies. A scholar is included among the top collaborators of Geraint Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geraint Davies. Geraint Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Platt, Georgina, Charles A. Peloquin, Julia Coit, et al.. (2025). Impact of Pharmacogenetics on Pharmacokinetics of First-Line Antituberculosis Drugs in the HIRIF Trial. The Journal of Infectious Diseases. 232(2). e258–e265.
2.
3.
Fuchs, Thomas J., Jackie Donovan, Samantha Irving, et al.. (2024). EPS7.07 Exploring the relationship of compartmentalised inflammation to structural and functional lung disease in CF: themysterious dichotomy of IL-6. Journal of Cystic Fibrosis. 23. S55–S55. 1 indexed citations
4.
Bharucha, Tehmina, Elizabeth Sutton, Nadja van Ginneken, et al.. (2022). Mouse models of Japanese encephalitis virus infection: A systematic review and meta-analysis using a meta-regression approach. PLoS neglected tropical diseases. 16(2). e0010116–e0010116. 14 indexed citations
5.
McIlleron, Helen, Adrie Bekker, Anneke C. Hesseling, et al.. (2022). Population pharmacokinetics of ethambutol in African children: a pooled analysis. Journal of Antimicrobial Chemotherapy. 77(7). 1949–1959. 3 indexed citations
6.
Denti, Paolo, Roeland E. Wasmann, Annelies Van Rie, et al.. (2021). Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study. Clinical Infectious Diseases. 75(1). 141–151. 18 indexed citations
7.
Chaplin, Marty, Jamie J Kirkham, Kerry Dwan, et al.. (2020). STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline. PLoS Medicine. 17(9). e1003344–e1003344. 30 indexed citations
8.
9.
Cohen, Daniëlle, et al.. (2019). Poor outcomes in recurrent tuberculosis: More than just drug resistance?. PLoS ONE. 14(5). e0215855–e0215855. 11 indexed citations
10.
Richardson, Marty, Jamie J Kirkham, Kerry Dwan, et al.. (2019). Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies. BMJ Open. 9(7). e030212–e030212. 3 indexed citations
11.
Davies, Geraint, et al.. (2019). Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs. PLoS Medicine. 16(7). e1002851–e1002851. 22 indexed citations
12.
Millard, James, Henry Pertinez, Laura Bonnett, et al.. (2018). Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation. Journal of Antimicrobial Chemotherapy. 73(7). 1755–1762. 27 indexed citations
13.
Velásquez, Gustavo E., Meredith B. Brooks, Julia Coit, et al.. (2018). Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 198(5). 657–666. 74 indexed citations
14.
Ellard, David R, Geraint Davies, Elisabeth Hertenstein, et al.. (2016). Behavioural interventions for people living with adult-onset primary dystonia: a systematic review. BMC Neurology. 16(1). 40–40. 13 indexed citations
15.
Sandhu, Harbinder, Geraint Davies, Nicole K. Y. Tang, et al.. (2016). Combined cognitive–behavioural and mindfulness programme for people living with dystonia: a proof-of-concept study. BMJ Open. 6(8). e011495–e011495. 12 indexed citations
16.
Mzinza, David, Derek J. Sloan, Kondwani Jambo, et al.. (2015). Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis. Tuberculosis. 95(4). 463–469. 3 indexed citations
17.
Davies, P.D.O., Stephen B. Gordon, & Geraint Davies. (2014). Clinical tuberculosis. (5th ed.). CRC Press eBooks. 1 indexed citations
18.
Davies, Jane C., Geraint Davies, Deborah R. Gill, et al.. (2011). SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF. Pediatric Pulmonology. 281–281. 4 indexed citations
19.
20.
Davies, Geraint & Eric L. Nuermberger. (2008). Pharmacokinetics and pharmacodynamics in the development of anti-tuberculosis drugs. Tuberculosis. 88. S65–S74. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Phillips Breakdown of academic impact, for papers by Rovina Ruslami Breakdown of academic impact, for papers by Amour Venter Breakdown of academic impact, for papers by Marc Weiner Breakdown of academic impact, for papers by Jotam G. Pasipanodya Breakdown of academic impact, for papers by Lubbe Wiesner Breakdown of academic impact, for papers by Kelly E. Dooley Breakdown of academic impact, for papers by Rodney Dawson Breakdown of academic impact, for papers by Paolo Denti Breakdown of academic impact, for papers by Shashikant Srivastava
Rankless by CCL
2026